A Pathogen Signature in Breast Cancer
Abnormal bacterial changes in breast tissue in a healthy woman may increase the risk and development of breast cancer. Similar evidence suggests that the same is also true for other cancers. Basal-like breast cancers, the majority of which are “triple negative,” make up 10-20% of all breast cancers. Sadly, women diagnosed with this type of breast cancer have a poorer prognosis when compared to those diagnosed with other kinds of breast cancer. This is due to the lack of targeted therapies for these tumors.
ExcaliVir has made important scientific discoveries regarding the microbial signature of triple negative breast cancer. These discoveries have the potential for creating a new frontier in the detection, monitoring, therapeutic selection and management of breast cancer.